August 14, 2024
The US Food and Drug Administration (FDA) has approved axatilimab (Niktimvo, Incyte Corporation) for the treatment of adult and pediatric patients with chronic graft versus host […]
August 14, 2024
Blood cancer death rates have dipped in recent decades, dramatically boosting 5-year survival rates in leukemia, lymphoma, and myeloma. Still, the three diseases were expected to […]
August 14, 2024
The European Commission has approved a combination of an immunotherapy agent with a poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of certain patients with primary […]
August 14, 2024
BRCA1 and BRCA2 pathogenic variants carry well-known associations with breast and ovarian cancers in women, which has led to robust clinical guidelines for early genetic testing […]
August 13, 2024
TOPLINE: A long-term follow-up analysis revealed that cisplatin administered at 100 mg/m2 once every 3 weeks provides superior locoregional control and may offer longer overall survival […]
August 13, 2024
(Reuters) – President Joe Biden will announce Tuesday he is putting $150 million in new federal funding towards developing technology to better help surgeons successfully remove […]
August 12, 2024
TOPLINE: A novel method combining genetic variants, symptoms, and patient characteristics is moderately successful at predicting which primary care patients are at high risk of developing […]
May 30, 2024
TOPLINE: A rapid recommendation update from the American Society of Clinical Oncology (ASCO) offers guidance on use of cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors, abemaciclib […]
May 29, 2024
TOPLINE: Low-income women with diabetes were less likely to receive adjuvant radiotherapy and chemotherapy to treat breast cancer, to complete their chemotherapy regimen, and to adhere […]